介入放射学会多学科立场声明:经皮消融治疗非小细胞肺癌及肺转移瘤
该立场声明由介入放射学会组织多学科写作组,通过全面文献检索(共63项研究)并采用改良德尔菲技术达成共识,制定了7条关于影像引导热消融治疗早期非小细胞肺癌、复发性肺癌及肺转移瘤的推荐意见,认为热消融是不可手术I期NSCLC、复发性NSCLC及肺转移患者的可接受治疗选择。
要点
- 影像引导热消融是不可手术I期NSCLC患者的可接受治疗选择。
- 复发性NSCLC及肺转移瘤患者也可考虑影像引导热消融治疗。
- 推荐意见基于63项研究证据,采用SIR证据分级系统进行分级。
诊断标准与关键数值
- 共制定7条关于影像引导热消融治疗肺部疾病的推荐意见,具体条款及推荐等级未在摘要中列出。
临床应用与阅片要点
- 对于不可手术的I期NSCLC、复发性NSCLC及肺转移瘤患者,可将影像引导热消融作为治疗选项进行多学科讨论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To state the Society of Interventional Radiology's position on the use of image-guided thermal ablation for the treatment of early stage non-small cell lung cancer, recurrent lung cancer, and metastatic disease to the lung.
MATERIALS AND METHODS: A multidisciplinary writing group, with expertise in treating lung cancer, conducted a comprehensive literature search to identify studies on the topic of interest. Recommendations were drafted and graded according to the updated SIR evidence grading system. A modified Delphi technique was used to achieve consensus agreement on the recommendation statements.
RESULTS: A total of 63 studies, including existing systematic reviews and meta-analysis, retrospective cohort studies, and single-arm trials were identified. The expert writing group developed and agreed on 7 recommendations on the use of image-guided thermal ablation in the lung.
CONCLUSION: SIR considers image-guided thermal ablation to be an acceptable treatment option for patients with inoperable Stage I NSCLC, those with recurrent NSCLC, as well as patients with metastatic lung disease.
引用
- Genshaft SJ, Suh RD, Abtin F, et al. Society of Interventional Radiology Multidisciplinary Position Statement on Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs: Endorsed by the Canadian Association for Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, and the Society of Interventional Oncology. J Vasc Interv Radiol. 2021. PMID: 34332724. doi:10.1016/j.jvir.2021.04.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。